Combining a PD-1 immune checkpoint inhibitor with standard chemotherapy improved quality of life for patients with advanced stomach cancer or esophageal cancer compared to chemotherapy alone, according to recent findings published in the Journal of Clinical Oncology.
retrieved 12 October 2023 from https://medicalxpress.com/news/2023-10-combination-therapy-quality-life-advanced.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use ourThank you for taking time to provide your feedback to the editors.
Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.Get weekly and/or daily updates delivered to your inbox.
This site uses cookies to assist with navigation, analyse your use of our services, collect data for ads personalisation and provide content from third parties. By using our site, you acknowledge that you have read and understand our
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Combination therapy effective in the treatment of relapsed immune thrombocytopenia in adultsIn the treatment of immune thrombocytopenia (ITP), glucocorticoids and IVIg are considered the primary therapeutic options. Typically, clinicians opt for either of these treatments when addressing ITP cases. The research pertaining to the combined use of these two medications has predominantly focused on emergency situations and cases related to ITP during pregnancy. There has been limited investigation into the treatment of relapsed ITP in adult patients.
Read more »
Large clinical trial identifies best strategy to prevent life-threatening health care-associated ICU infectionsA large multi-state study by the Centers for Disease Control and Prevention, the Harvard Pilgrim Health Care Institute, HCA Healthcare, and the University of California, Irvine has found that a nasal antibiotic ointment, mupirocin, which is currently used daily for intensive care unit (ICU) patients in only one-third of U.S. hospitals, is highly effective at preventing Staphylococcus aureus infections in critically ill patients, outperforming an antiseptic solution.
Read more »
Clinical trial tests creatine monohydrate and exercise to preserve muscle mass in prostate cancer patientsThe National Cancer Institute awarded investigators at Huntsman Cancer Institute a grant totaling more than $3 million to conduct a clinical trial to see if combining creatine monohydrate supplementation and resistance exercise training helps preserve muscle in people who have metastatic prostate cancer.
Read more »
OrganaBio launches new division to meet growing demand for decentralized clinical trial supportOrganaBio, the Contract Technology Development and Manufacturing Organization (CTDMO) specializing in solutions for cell and immunotherapy development, today announces the official launch of Cell Processing and Cryopreservation (CPC) Services, a new division of OrganaBio.
Read more »
Clinical trial finds herbal medicine Sailuotong effective for brain health in older peopleWestern Sydney University's NICM Health Research Institute has led a world-first clinical trial in Australia that offers new hope in the treatment of mild cognitive impairment (MCI) among older people. The trial's results, published in the journal Alzheimer's and Dementia, signal the efficacy and safety of Sailuotong (SLT), a novel herbal extract, as a potential treatment for MCI.
Read more »
Liverpool’s ‘Famous Five’: How Jurgen Klopp built Europe’s most formidable attackLiverpool boast an envious forward line - but how do their five forwards work best in combination?
Read more »